K-HUB
Research, Development & Beyond
KHUB, a group of companies including Hanmi Science, is driven by the mission to build a global vaccine hub to ensure global supply and distribution of vaccines against infectious diseases with our professional research and production capabilities.
MEDIA ARCHIVESmore
-
New influenza vaccine strategies aim to enhance protection with T-cell responses
-
Scientists develop trivalent vaccine offering broad protection against coronaviruses
-
2024 Medical Reformation Think Tank Group MR-TTG
-
European initiative aims to advance the understanding of RNA communication
-
Latest Covid-19 vaccine offers strong protection against symptomatic infection, including from JN.1, early CDC data shows
-
Are pan-coronavirus vaccines an achievable goal in providing broad protection against human coronaviruses?
NEWS ROOMmore
-
디엑스앤브이엑스, 'SEACare 2024' 참석…글로벌 사업 확장 지속
2024-04-26
-
디엑스앤브이엑스, 개인 맞춤형 건기식 사업 본격화
2024-04-02
-
DXVX "세포치료제 동반진단 서비스 시장 확대"
2024-03-22
-
2024 Medical Reformation Think Tank Group MR-TTG
2024-03-08
-
DXVX "의료 개혁 직접 지원하는 전문 씽크탱크로 성장할 것"
2024-03-04
-
디엑스앤브이엑스, 중국 의약품 제품군 확대…구강염 치료제 출시
2024-02-26
-
DXVX, '코리 헬스케어 4.0' 비대면 진료 서비스 추진
2024-02-01
-
디엑스앤브이엑스(Dx&Vx), 동반진단 CLIDEX 사업 매출 본격화
2024-01-29